Antidiabetic drugs and the risk of cancer: beneficial, neutral, or detrimental?
The prevalence of diabetes mellitus is rapidly rising, especially in low- and middle-income countries. Also, early-onset diabetes is on the rise, and millions of individuals have to be on antidiabetic medications for a prolonged period. Therefore, more people are getting exposed to the adverse effec...
Saved in:
| Main Authors: | Azeez Taoreed Adegoke, Folorunso Sharif Adeniyi, Eguzozie Chinedu, Adegboyega Adeleke Adedapo |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Sciendo
2021-08-01
|
| Series: | Forum of Clinical Oncology |
| Subjects: | |
| Online Access: | https://doi.org/10.2478/fco-2021-0014 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Prevalence of adherence to oral antidiabetic drugs in patients with type 2 diabetes: A systematic review and meta‐analysis
by: Kansak Boonpattharatthiti, et al.
Published: (2024-11-01) -
White adipose tissue in type 2 diabetes and the effect of antidiabetic drugs
by: Yixuan Zhao, et al.
Published: (2025-04-01) -
Metabolic imbalance and brain tumors: The interlinking metabolic pathways and therapeutic actions of antidiabetic drugs
by: Young-Kook Kim, et al.
Published: (2025-05-01) -
Risk of hepatocellular carcinoma in adults exposed to oral antidiabetic drugs: a systematic review
by: Shadman Newaz, et al.
Published: (2025-06-01) -
ANALYSIS OF ANTIDIABETIC DRUGS ASSORTMENT REPRESENTED ON THE PHARMACEUTICAL MARKET OF SAINT PETERSBURG
by: Yu. V. Miroshnichenko, et al.
Published: (2015-10-01)